These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9590006

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rapid nonradioactive assay for the detection of the common French Canadian tyrosinemia type I mutation.
    Grompe M, al-Dhalimy M.
    Hum Mutat; 1995; 5(1):105. PubMed ID: 7728147
    [No Abstract] [Full Text] [Related]

  • 3. [Hereditary tyrosinemia type II].
    Endo F.
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):134-6. PubMed ID: 9590007
    [No Abstract] [Full Text] [Related]

  • 4. Tyrosine and its catabolites: from disease to cancer.
    Tanguay RM, Jorquera R, Poudrier J, St-Louis M.
    Acta Biochim Pol; 1996; 43(1):209-16. PubMed ID: 8790725
    [Abstract] [Full Text] [Related]

  • 5. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.
    Grompe M, St-Louis M, Demers SI, al-Dhalimy M, Leclerc B, Tanguay RM.
    N Engl J Med; 1994 Aug 11; 331(6):353-7. PubMed ID: 8028615
    [Abstract] [Full Text] [Related]

  • 6. Frequency of the IVS12 + 5G-->A splice mutation of the fumarylacetoacetate hydrolase gene in carriers of hereditary tyrosinaemia in the French Canadian population of Saguenay-Lac-St-Jean.
    Poudrier J, St-Louis M, Lettre F, Gibson K, Prévost C, Larochelle J, Tanguay RM.
    Prenat Diagn; 1996 Jan 11; 16(1):59-64. PubMed ID: 8821854
    [Abstract] [Full Text] [Related]

  • 7. Hereditary tyrosinemia type I: lack of correlation between clinical findings and amount of immunoreactive fumarylacetoacetase protein.
    Kvittingen EA, Rootwelt H, van Dam T, van Faassen H, Berger R.
    Pediatr Res; 1992 Jan 11; 31(1):43-6. PubMed ID: 1594329
    [Abstract] [Full Text] [Related]

  • 8. Mutation analysis for prenatal diagnosis of hereditary tyrosinaemia type 1.
    Mustonen A, Ploos van Amstel HK, Berger R, Salo MK, Viinikka L, Simola KO.
    Prenat Diagn; 1997 Oct 11; 17(10):964-6. PubMed ID: 9358577
    [Abstract] [Full Text] [Related]

  • 9. Different clinical forms of hereditary tyrosinemia (type I) in patients with identical genotypes.
    Poudrier J, Lettre F, Scriver CR, Larochelle J, Tanguay RM.
    Mol Genet Metab; 1998 Jun 11; 64(2):119-25. PubMed ID: 9705236
    [Abstract] [Full Text] [Related]

  • 10. Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect.
    Kvittingen EA, Rootwelt H, Brandtzaeg P, Bergan A, Berger R.
    J Clin Invest; 1993 Apr 11; 91(4):1816-21. PubMed ID: 8473520
    [Abstract] [Full Text] [Related]

  • 11. [Tyrosinemia].
    Salo MK.
    Duodecim; 1992 Apr 11; 108(9):841-3. PubMed ID: 1366298
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.
    Kvittingen EA, Brodtkorb E.
    Scand J Clin Lab Invest Suppl; 1986 Apr 11; 184():35-40. PubMed ID: 3473612
    [Abstract] [Full Text] [Related]

  • 15. Deficiency of fumarylacetoacetase without hereditary tyrosinemia.
    Kvittingen EA, Børresen AL, Stokke O, van der Hagen CB, Lie SO.
    Clin Genet; 1985 Jun 11; 27(6):550-4. PubMed ID: 4017276
    [Abstract] [Full Text] [Related]

  • 16. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
    St-Louis M, Tanguay RM.
    Hum Mutat; 1997 Jun 11; 9(4):291-9. PubMed ID: 9101289
    [Abstract] [Full Text] [Related]

  • 17. Self-induced correction of the genetic defect in tyrosinemia type I.
    Kvittingen EA, Rootwelt H, Berger R, Brandtzaeg P.
    J Clin Invest; 1994 Oct 11; 94(4):1657-61. PubMed ID: 7929843
    [Abstract] [Full Text] [Related]

  • 18. Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries.
    Bergman AJ, van den Berg IE, Brink W, Poll-The BT, Ploos van Amstel JK, Berger R.
    Hum Mutat; 1998 Oct 11; 12(1):19-26. PubMed ID: 9633815
    [Abstract] [Full Text] [Related]

  • 19. Walking the ethical highwire: genetic screening and hereditary tyrosinemia.
    Romero R, Lavine JE.
    Hepatology; 1995 Apr 11; 21(4):1193-5. PubMed ID: 7705795
    [No Abstract] [Full Text] [Related]

  • 20. The human fumarylacetoacetase gene: characterisation of restriction fragment length polymorphisms and identification of haplotypes in tyrosinemia type 1 and pseudodeficiency.
    Rootwelt H, Kvittingen EA, Høie K, Agsteribbe E, Hartog M, van Faassen H, Berger R.
    Hum Genet; 1992 May 11; 89(2):229-33. PubMed ID: 1350265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.